A prospective study of serum amyloid A in relation to plasma administration in neonatal foals

Res Vet Sci. 2022 Dec 10:151:96-99. doi: 10.1016/j.rvsc.2022.06.028. Epub 2022 Jul 10.

Abstract

SAA is a commonly used biomarker for measuring acute inflammation in equine practice, and the administration of prophylactic plasma to foals is a routine practice in large breeding farms. Despite this, limited information is available on the values of SAA in healthy or sick neonatal foals following this common procedure. A prospective study was conducted with 31 foals from a veterinary hospital in Texas in one year. Enrolled foals were part of a foaling program, where a prophylactic hyperimmunized plasma was administered 12 h after birth. Blood was collected for SAA measurements at birth and at 12 h (pre-plasma), 13 h (post-plasma), 24 h, 48 h, 72 h, and 96 h. Eight of the foals were clinically ill prior to plasma administration, and 23 foals were clinically normal. The mean SAA of all foals at birth was 1 μg/mL, increased to 11 μg/mL at 12 h (pre-plasma), and at 13 h (post-plasma) was 155 μg/mL. At 13 h, 65% of normal foals and 63% of sick foals had an SAA value >100 μg/mL. Transient but substantial increases in SAA following prophylactic plasma administration were frequently observed in this study. Veterinarians evaluating neonatal foals for clinical disease in the field should be cognizant of the timing of blood sampling in relation to plasma administration.

Keywords: Failure of passive transfer; Foal; Plasma; Serum amyloid A.

MeSH terms

  • Animals
  • Animals, Newborn
  • Biomarkers
  • Horse Diseases*
  • Horses
  • Prospective Studies
  • Serum Amyloid A Protein*

Substances

  • Biomarkers
  • Serum Amyloid A Protein